Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Liver Transplantation

  Free Subscription


Articles published in Hepatology

Retrieve available abstracts of 185 articles:
HTML format



Single Articles


    July 2021
  1. DE GOEIJ FHC, Schlegel A, Muiesan P, Guarrera JV, et al
    Hypothermic oxygenated machine perfusion protects from cholangiopathy in DCD liver transplantation.
    Hepatology. 2021 Jul 7. doi: 10.1002/hep.32044.
    PubMed     Abstract available


    June 2021
  2. HIRAO H, Ito T, Kadono K, Kojima H, et al
    Donor Hepatic Occult Collagen Deposition Predisposes to Peri-transplant Stress and Impacts Human Liver Transplantation.
    Hepatology. 2021 Jun 25. doi: 10.1002/hep.32030.
    PubMed     Abstract available


  3. WONG TC, Lee VH, Law AL, Pang HH, et al
    Prospective study of stereotactic body radiation therapy for hepatocellular carcinoma on waitlist for liver transplant.
    Hepatology. 2021 Jun 6. doi: 10.1002/hep.31992.
    PubMed     Abstract available


  4. ROSENBLATT R, Lee H, Liapakis A, Lunsford KE, et al
    Equitable access to liver transplant: Bridging the gaps in the social determinants of health.
    Hepatology. 2021 Jun 1. doi: 10.1002/hep.31986.
    PubMed     Abstract available


    May 2021
  5. MARTINEZ M, Perito ER, Valentino P, Mack CL, et al
    Recurrence of primary sclerosing cholangitis after liver transplant in children: an international observational study.
    Hepatology. 2021 May 18. doi: 10.1002/hep.31911.
    PubMed     Abstract available


  6. MEUNIER L, Faure S, Meszaros M
    Letter to the Editor: Cancer after liver transplant: don't forget tobacco and tacrolimus.
    Hepatology. 2021 May 15. doi: 10.1002/hep.31899.
    PubMed     Abstract available


    March 2021
  7. ROSENBLATT R, Wahid N, Halazun KJ, Kaplan A, et al
    Black Patients Have Unequal Access to Listing for Liver Transplantation in the United States.
    Hepatology. 2021 Mar 29. doi: 10.1002/hep.31837.
    PubMed     Abstract available


  8. VANDERWERKEN D, Wood NL, Segev D, Gentry S, et al
    The Precise Relationship Between MELD and Survival Without a Liver Transplant.
    Hepatology. 2021 Mar 2. doi: 10.1002/hep.31781.
    PubMed     Abstract available


    February 2021
  9. HERCUN J, Parikh E, Kleiner DE, Fuss I, et al
    Recurrent nodular regenerative hyperplasia post-liver transplantation in common variable immunodeficiency.
    Hepatology. 2021 Feb 27. doi: 10.1002/hep.31775.
    PubMed     Abstract available


  10. NASSER-GHODSI N, Mara K, Watt KD
    De novo Colorectal and Pancreatic Cancer in Liver Transplant Recipients: Identifying the Higher Risk Populations.
    Hepatology. 2021 Feb 5. doi: 10.1002/hep.31731.
    PubMed     Abstract available


    January 2021
  11. JIN L, Li X
    Letter to the Editor: Prognostic value of B-type natriuretic peptide in liver transplant patients.
    Hepatology. 2021 Jan 18. doi: 10.1002/hep.31721.
    PubMed     Abstract available


  12. KWON HM, Jang HY, Hwang GS
    Reply to Letter to the Editors: "Prognostic value of B-type natriuretic peptide in liver transplant patients".
    Hepatology. 2021 Jan 18. doi: 10.1002/hep.31722.
    PubMed     Abstract available


  13. SARKAR M, Brady CW, Fleckenstein J, Forde KA, et al
    Reproductive Health and Liver Disease: Practice Guidance by the American Association for the Study of Liver Diseases.
    Hepatology. 2021;73:318-365.
    PubMed    


  14. LEONIS MA, Miethke AG, Fei L, Maynor S, et al
    Four Biomarkers Linked to Activation of Cluster of Differentiation 8-Positive Lymphocytes Predict Clinical Outcomes in Pediatric Acute Liver Failure.
    Hepatology. 2021;73:233-246.
    PubMed     Abstract available


    November 2020
  15. HAFEZI M, Lin M, Chia A, Chua A, et al
    Immunosuppressive Drug Resistant Armored TCR T cells for immune-therapy of HCC in liver transplant patients.
    Hepatology. 2020 Nov 29. doi: 10.1002/hep.31662.
    PubMed     Abstract available


  16. KWON HM, Moon YJ, Kim KS, Shin WJ, et al
    Prognostic value of B-type natriuretic peptide in liver transplant patients: Implication in post-transplant mortality.
    Hepatology. 2020 Nov 28. doi: 10.1002/hep.31661.
    PubMed     Abstract available


  17. BARMAN PM, VanWagner LB
    Cardiac Risk Assessment in Liver Transplant Candidates: Current Controversies and Future Directions.
    Hepatology. 2020 Nov 20. doi: 10.1002/hep.31647.
    PubMed     Abstract available


  18. POLI E, Verstuyft C, Guettier C, Duclos Vallee JC, et al
    Reply to "Letter to the Editor: Post-Liver Transplantation Sinusoidal Obstruction Syndrome and immunosuppressive drugs: causality of MMF or tacrolimus?"
    Hepatology. 2020 Nov 17. doi: 10.1002/hep.31635.
    PubMed     Abstract available


  19. LOUSTAUD-RATTI V, Anneraud A, Carrier P, Debette-Gratien M, et al
    Letter to the Editor: Post-Liver Transplantation Sinusoidal Obstruction Syndrome and immunosuppressive drugs: causality of MMF or tacrolimus?
    Hepatology. 2020 Nov 13. doi: 10.1002/hep.31633.
    PubMed     Abstract available


    October 2020
  20. BROWN SA, Izzy M, Watt KD
    Pharmacotherapy for Weight Loss in Cirrhosis and Liver Transplantation: Translating the Data and Underutilized Potential.
    Hepatology. 2020 Oct 12. doi: 10.1002/hep.31595.
    PubMed     Abstract available


  21. WONG TC, Yan-Yue Fung J, Pang HH, Leung CK, et al
    Analysis of survival benefits of living vs. deceased donor liver transplant in high MELD and hepatorenal syndrome.
    Hepatology. 2020 Oct 2. doi: 10.1002/hep.31584.
    PubMed     Abstract available


    September 2020
  22. RABIEE A, Sadowski B, Adeniji N, Perumalswami P, et al
    Liver Injury in Liver Transplant Recipients with Coronavirus Disease 2019 (COVID-19): US Multicenter Experience.
    Hepatology. 2020 Sep 22. doi: 10.1002/hep.31574.
    PubMed     Abstract available


  23. JASPER S, Hakeem AR, Vij M, Sachan D, et al
    First report of toxin-induced graft injury following liver transplantation for Yellow Phosphorus Poisoning.
    Hepatology. 2020 Sep 16. doi: 10.1002/hep.31553.
    PubMed     Abstract available


  24. PIANO S, Gambino C, Vettore E, Calvino V, et al
    Response to Terlipressin and Albumin Is Associated With Improved Liver Transplant Outcomes in Patients With Hepatorenal Syndrome.
    Hepatology. 2020 Sep 1. doi: 10.1002/hep.31529.
    PubMed     Abstract available


  25. DA BL, Im GY, Schiano TD
    Coronavirus Disease 2019 Hangover: A Rising Tide of Alcohol Use Disorder and Alcohol-Associated Liver Disease.
    Hepatology. 2020;72:1102-1108.
    PubMed     Abstract available


    August 2020
  26. FENG S, Bucuvalas JC, Mazariegos GV, Magee JC, et al
    Efficacy and Safety of Immunosuppression Withdrawal in Pediatric Liver Transplant Recipients: Moving Towards Personalized Management.
    Hepatology. 2020 Aug 12. doi: 10.1002/hep.31520.
    PubMed     Abstract available


  27. KIM WH, Yang SM, Lee KH
    Letter to the Editor: Appraisal of Cardiac Ejection Fraction With Liver Disease Severity.
    Hepatology. 2020;72:783.
    PubMed    


  28. KWON HM, Hwang GS
    Reply.
    Hepatology. 2020;72:784.
    PubMed    


    July 2020
  29. REIBERGER T, Mandorfer M
    "Perioperative Presentation of COVID-19 Disease in a Liver Transplant Recipient".
    Hepatology. 2020 Jul 12. doi: 10.1002/hep.31458.
    PubMed     Abstract available


  30. THAN NN, Cataluna JG, Majumdar A
    Acute confusion post liver transplantation: HE or not HE, that is the question.
    Hepatology. 2020 Jul 6. doi: 10.1002/hep.31452.
    PubMed     Abstract available


    June 2020
  31. COTTER TG, Wang J, Peeraphatdit T, Sandikci B, et al
    Simultaneous Heart-Liver Transplantation for Congenital Heart Disease in the USA: Rapidly Increasing with Acceptable Outcomes.
    Hepatology. 2020 Jun 19. doi: 10.1002/hep.31426.
    PubMed     Abstract available


  32. RUSSO MW, Fix OK, Koteish AA, Duggan K, et al
    Modeling the Hepatology Workforce in the United States: A Predicted Critical Shortage.
    Hepatology. 2020 Jun 17. doi: 10.1002/hep.31425.
    PubMed     Abstract available


  33. KARDASHIAN A, Ge J, McCulloch CE, Kappus MR, et al
    Identifying an Optimal Liver Frailty Index Cutoff to Predict Waitlist Mortality in Liver Transplant Candidates.
    Hepatology. 2020 Jun 3. doi: 10.1002/hep.31406.
    PubMed     Abstract available


  34. THALJI L, Thalji NM, Heimbach JK, Ibrahim SH, et al
    Renal Function Parameters and Serum Sodium Enhance Prediction of Waitlist Outcomes in Pediatric Liver Transplantation.
    Hepatology. 2020 Jun 2. doi: 10.1002/hep.31397.
    PubMed     Abstract available


    May 2020
  35. SOSA RA, Terry AQ, Kaldas FM, Jin YP, et al
    Disulfide-HMGB1 Drives Ischemia-Reperfusion Injury in Human Liver Transplantation.
    Hepatology. 2020 May 19. doi: 10.1002/hep.31324.
    PubMed     Abstract available


  36. GABR A, Kulik L, Mouli S, Riaz A, et al
    Liver Transplantation Following Yttrium-90 Radioembolization: 15-year Experience in 207-Patient Cohort.
    Hepatology. 2020 May 16. doi: 10.1002/hep.31318.
    PubMed     Abstract available


    April 2020
  37. KUMAR A
    Letter to the Editor: Role of Sorafenib in Liver Transplantation Outcomes of Patients with Hepatocellular Carcinoma Presenting Beyond Milan Criteria?
    Hepatology. 2020 Apr 22. doi: 10.1002/hep.31285.
    PubMed     Abstract available


  38. KARDASHIAN A, Agopian V
    Reply to: "Role of Sorafenib in Liver Transplantation Outcomes of Patients with Hepatocellular Carcinoma Presenting Beyond Milan Criteria?"
    Hepatology. 2020 Apr 20. doi: 10.1002/hep.31283.
    PubMed     Abstract available


  39. FIX OK, Hameed B, Fontana RJ, Kwok RM, et al
    Clinical Best Practice Advice for Hepatology and Liver Transplant Providers During the COVID-19 Pandemic: AASLD Expert Panel Consensus Statement.
    Hepatology. 2020 Apr 16. doi: 10.1002/hep.31281.
    PubMed     Abstract available


  40. KHALAF RT, Sokol RJ
    New Insights Into Intestinal Failure-Associated Liver Disease in Children.
    Hepatology. 2020;71:1486-1498.
    PubMed     Abstract available


    March 2020
  41. QIN J, Wang H, Qin X, Zhang P, et al
    Perioperative Presentation of COVID-19 Disease in a Liver Transplant Recipient.
    Hepatology. 2020 Mar 27. doi: 10.1002/hep.31257.
    PubMed     Abstract available


  42. SCHWACHA-EIPPER B, Minciuna I, Banz V, Dufour JF, et al
    Immunotherapy as a downstaging therapy for liver transplantation.
    Hepatology. 2020 Mar 14. doi: 10.1002/hep.31234.
    PubMed     Abstract available


  43. NAGAI S, Kitajima T, Yeddula S, Salgia R, et al
    Effect of mandatory 6-month waiting period on waitlist and transplant outcomes in patients with hepatocellular carcinoma.
    Hepatology. 2020 Mar 10. doi: 10.1002/hep.31223.
    PubMed     Abstract available


  44. KARDASHIAN A, Florman SS, Haydel B, Ruiz RM, et al
    Liver Transplantation Outcomes in a U.S. Multicenter Cohort of 789 Patients with Hepatocellular Carcinoma Presenting Beyond Milan Criteria.
    Hepatology. 2020 Mar 2. doi: 10.1002/hep.31210.
    PubMed     Abstract available


  45. TANER T, Heimbach JK
    Something Wicked this Way Comes.
    Hepatology. 2020;71:1119-1121.
    PubMed    


  46. SPANN A, Yasodhara A, Kang J, Watt K, et al
    Applying Machine Learning in Liver Disease and Transplantation: A Comprehensive Review.
    Hepatology. 2020;71:1093-1105.
    PubMed     Abstract available


    February 2020
  47. JUNGER H, Knoppke B, Weigand K, Evert K, et al
    Living donor liver transplantation from hepatitis C-infected donor to hepatitis C-infected recipient.
    Hepatology. 2020 Feb 17. doi: 10.1002/hep.31185.
    PubMed     Abstract available


  48. DEROO R, Trepo E, Holvoet T, De Pauw M, et al
    Vasomodulators and liver transplantation for portopulmonary hypertension: evidence from a systematic review and meta-analysis.
    Hepatology. 2020 Feb 4. doi: 10.1002/hep.31164.
    PubMed     Abstract available


    January 2020
  49. WALLACE D, Cowling T, PcPhail MJ, Brown SE, et al
    Assessing the time-dependent impact of performance status on outcomes after liver transplantation.
    Hepatology. 2020 Jan 22. doi: 10.1002/hep.31124.
    PubMed     Abstract available


  50. KOLB JM, Conzen K, Wachs M, Crossno J Jr, et al
    Liver Transplantation for Decompensated Cirrhosis Secondary to Telomerase Reverse Transcriptase (TERT) Mutation.
    Hepatology. 2020 Jan 14. doi: 10.1002/hep.31111.
    PubMed     Abstract available


  51. CRABB DW, Im GY, Szabo G, Mellinger JL, et al
    Diagnosis and Treatment of Alcohol-Associated Liver Diseases: 2019 Practice Guidance From the American Association for the Study of Liver Diseases.
    Hepatology. 2020;71:306-333.
    PubMed    


    December 2019
  52. DERY KJ, Nakamura K, Kadono K, Hirao H, et al
    Human Antigen R (HuR): A New Regulator of Heme Oxygenase-1 Cytoprotection in Mouse and Human Liver Transplant Injury.
    Hepatology. 2019 Dec 27. doi: 10.1002/hep.31093.
    PubMed     Abstract available


  53. DEVARBHAVI H
    Response to "Liver Transplantation for Acute Liver Failure Due to Dengue Fever" by Galante A et al. Hepatology. 2019;70:1863-65.
    Hepatology. 2019 Dec 17. doi: 10.1002/hep.31074.
    PubMed     Abstract available


    November 2019
  54. GYORI GP, Pereyra D, Rumpf B, Hackl H, et al
    Von Willebrand factor facilitates MELD-independent risk stratification on the waiting list for liver transplantation.
    Hepatology. 2019 Nov 27. doi: 10.1002/hep.31047.
    PubMed     Abstract available


  55. LEVITSKY J, Burrell BE, Kanaparthi S, Turka LA, et al
    Immunosuppression withdrawal in liver transplant recipients on sirolimus.
    Hepatology. 2019 Nov 13. doi: 10.1002/hep.31036.
    PubMed     Abstract available


  56. LEE BP, Vittinghoff E, Pletcher MJ, Dodge JL, et al
    Medicaid Policy and Liver Transplant for Alcohol-Related Liver Disease.
    Hepatology. 2019 Nov 8. doi: 10.1002/hep.31027.
    PubMed     Abstract available


  57. KUTKUT I, Rachwan RJ, Timsina LR, Ghabril MS, et al
    Pre-Liver Transplant Cardiac Catheterization is Associated with Low Rate of Myocardial Infarction and Cardiac Mortality.
    Hepatology. 2019 Nov 7. doi: 10.1002/hep.31023.
    PubMed     Abstract available


    October 2019
  58. KAPILA N, Menon KVN, Al-Khalloufi K, Vanatta JM, et al
    HCV NAT positive solid organ allografts transplanted into HCV negative recipients: A real-world experience.
    Hepatology. 2019 Oct 28. doi: 10.1002/hep.31011.
    PubMed     Abstract available


  59. POLI E, Kounis I, Guettier C, Verstuyft C, et al
    Post-Liver Transplantation Sinusoidal Obstruction Syndrome With Refractory Ascites Induced by Mycophenolate Mofetil.
    Hepatology. 2019 Oct 9. doi: 10.1002/hep.30984.
    PubMed     Abstract available


    September 2019
  60. SIDDIQUI MB, Siddiqui MS
    Reply letter for: HEP-18-1513.R3 - Small Dense Low-Density Lipoprotein Cholesterol Predicts Cardiovascular Events In Liver Transplant Recipients.
    Hepatology. 2019 Sep 26. doi: 10.1002/hep.30971.
    PubMed     Abstract available


  61. WANG P, Zhong L
    Lipoproteins Sub-particles and Cardiovascular Risk In liver transplantation: More details, More Significance.
    Hepatology. 2019 Sep 26. doi: 10.1002/hep.30972.
    PubMed     Abstract available


  62. ASRANI SK, Jennings LW, Kim WR, Kamath P, et al
    MELD-GRAIL-Na: Glomerular filtration rate and mortality on Liver-Transplant Waiting List.
    Hepatology. 2019 Sep 16. doi: 10.1002/hep.30932.
    PubMed     Abstract available


  63. KIM HB, Elisofon SA
    Hepatology Elsewhere.
    Hepatology. 2019 Sep 13. doi: 10.1002/hep.30935.
    PubMed     Abstract available


  64. BI X, Deising A, Frenette C
    Acute Liver Failure from Exertional Heatstroke Can Result in Excellent Long-term Survival with Liver Transplantation.
    Hepatology. 2019 Sep 11. doi: 10.1002/hep.30938.
    PubMed     Abstract available


  65. LEVITSKY J, Asrani SK, Klintmalm G, Schiano T, et al
    Discovery and validation of a biomarker model (preserve) predictive of renal outcomes after liver transplantation.
    Hepatology. 2019 Sep 11. doi: 10.1002/hep.30939.
    PubMed     Abstract available


  66. LEE BP, Terrault NA
    Liver Transplantation in Unauthorized Immigrants in the United States.
    Hepatology. 2019 Sep 5. doi: 10.1002/hep.30926.
    PubMed     Abstract available


    August 2019
  67. KWON HM, Moon YJ, Jung KW, Park YS, et al
    Appraisal of cardiac ejection fraction with liver disease severity: Implication in post-liver transplantation mortality.
    Hepatology. 2019 Aug 28. doi: 10.1002/hep.30913.
    PubMed     Abstract available


    July 2019
  68. MEHTA N, Dodge JL, Grab JD, Yao FY, et al
    National Experience on Down-staging of Hepatocellular Carcinoma before Liver Transplant: Influence of Tumor Burden, AFP, and Wait Time.
    Hepatology. 2019 Jul 25. doi: 10.1002/hep.30879.
    PubMed     Abstract available


  69. CASTELLOTE J, Mora Lujan JM, Riera-Mestre A
    mTOR-inhibitor-based immunosuppression following liver transplantation for Hereditary Hemorrhagic Telangiectasia.
    Hepatology. 2019 Jul 22. doi: 10.1002/hep.30870.
    PubMed     Abstract available


  70. CHOUDHARY NS, Saigal S, Soin AS
    Liver transplantation for Acute Liver Failure due to Dengue fever: first successful reported case worldwide.
    Hepatology. 2019 Jul 22. doi: 10.1002/hep.30869.
    PubMed     Abstract available


  71. MARRERO JA
    Obesity and Liver Disease: The New Era of Liver Transplantation.
    Hepatology. 2019 Jul 13. doi: 10.1002/hep.30854.
    PubMed     Abstract available


    June 2019
  72. FIRL DJ, Sasaki K, Agopian VG, Gorgen A, et al
    Charting the Path Forward for Risk Prediction in Liver Transplant for HCC: International Validation of HALTHCC amongst 4,089 patients.
    Hepatology. 2019 Jun 27. doi: 10.1002/hep.30838.
    PubMed     Abstract available


  73. CAREY EJ, Lai JC, Sonnenday C, Tapper EB, et al
    A North American Expert Opinion Statement on Sarcopenia in Liver Transplantation.
    Hepatology. 2019 Jun 20. doi: 10.1002/hep.30828.
    PubMed     Abstract available


  74. GALANTE A, Adeyi O, Lau L, Humar A, et al
    Liver transplantation for Acute Liver Failure due to Dengue fever: first successful reported case worldwide.
    Hepatology. 2019 Jun 4. doi: 10.1002/hep.30803.
    PubMed     Abstract available


    May 2019
  75. OEY RC, Spaander MCW, van Buuren HR, de Man RA, et al
    Screening colonoscopy in patients evaluated for liver transplantation: a closer look in a defined population.
    Hepatology. 2019 May 24. doi: 10.1002/hep.30781.
    PubMed     Abstract available


  76. MBACHI C, Abegunde AT
    Screening Colonoscopy in Patients Evaluated for Liver Transplant: Look before You Leap.
    Hepatology. 2019 May 23. doi: 10.1002/hep.30786.
    PubMed     Abstract available


  77. JIANG N, Li X, Xing YF, Qiao YD, et al
    Local regional therapy before liver transplantation for hepatocellular carcinoma.
    Hepatology. 2019 May 15. doi: 10.1002/hep.30769.
    PubMed     Abstract available


    April 2019
  78. LEVITSKY J, Asrani SK, Abecassis M, Ruiz R, et al
    External Validation of a Pre-Transplant Biomarker Model (REVERSE) Predictive of Renal Recovery after Liver Transplantation.
    Hepatology. 2019 Apr 19. doi: 10.1002/hep.30667.
    PubMed     Abstract available


    February 2019
  79. SINHA J, Mehta N, Dodge JL, Poltavskiy E, et al
    Are There Upper Limits in Tumor Burden for Down-staging of HCC to Liver Transplant? Analysis of the All-comers Protocol.
    Hepatology. 2019 Feb 19. doi: 10.1002/hep.30570.
    PubMed     Abstract available


  80. SCHLEGEL A, Dutkowski P
    Repair or Prevent - What is the real impact of normothermic machine perfusion in liver transplantation?
    Hepatology. 2019 Feb 17. doi: 10.1002/hep.30567.
    PubMed     Abstract available


  81. OEY RC, van Tilburg L, Erler NS, Metselaar HJ, et al
    The yield and safety of screening colonoscopy in patients evaluated for liver transplantation.
    Hepatology. 2019 Feb 14. doi: 10.1002/hep.30562.
    PubMed     Abstract available


  82. CHIU V, Hogen R, Sher L, Wade N, et al
    Telomerase Variants in Patients with Cirrhosis Awaiting Liver Transplantation.
    Hepatology. 2019 Feb 14. doi: 10.1002/hep.30557.
    PubMed     Abstract available


    January 2019
  83. COTTER TG, Paul S, Sandikci B, Couri T, et al
    Increasing Utilization and Excellent Initial Outcomes Following Liver Transplant of HCV-Viremic Donors into HCV-Negative Recipients.
    Hepatology. 2019 Jan 31. doi: 10.1002/hep.30540.
    PubMed     Abstract available


  84. SIDDIQUI MB, Arshad T, Patel S, Lee E, et al
    Small Dense Low-Density Lipoprotein Cholesterol Predicts Cardiovascular Events In Liver Transplant Recipients.
    Hepatology. 2019 Jan 23. doi: 10.1002/hep.30518.
    PubMed     Abstract available


    December 2018
  85. GOODE EC, Clark AB, Mells GM, Srivastava B, et al
    Factors Associated With Outcomes of Patients With Primary Sclerosing Cholangitis and Development and Validation of a Risk Scoring System.
    Hepatology. 2018 Dec 19. doi: 10.1002/hep.30479.
    PubMed     Abstract available


  86. LEE BP, Vittinghoff E, Hsu C, Han H, et al
    Predicting Low-Risk for Sustained Alcohol Use After Early Liver Transplant for Acute Alcoholic Hepatitis: The SALT Score.
    Hepatology. 2018 Dec 18. doi: 10.1002/hep.30478.
    PubMed     Abstract available


  87. RIVEIRO-BARCIELA M, Gironella M, Senin A, Salcedo MT, et al
    Decompensated liver disease due to primary hepatic amyloidosis: Is liver transplantation still mandatory?
    Hepatology. 2018 Dec 18. doi: 10.1002/hep.30464.
    PubMed     Abstract available


  88. SOLGA SF, Serper M, Young RA, Forde KA, et al
    Transplantation for Alcoholic Hepatitis: Are We Achieving Justice and Utility?
    Hepatology. 2018 Dec 18. doi: 10.1002/hep.30471.
    PubMed     Abstract available


  89. DUMORTIER J, Dupuis-Girod S, Valette PJ, Valent A, et al
    Recurrence of hereditary hemorrhagic telangiectasia after liver transplantation: clinical implications and physiopathological insights.
    Hepatology. 2018 Dec 14. doi: 10.1002/hep.30424.
    PubMed     Abstract available


  90. MEHTA N, Dodge JL, Roberts JP, Hirose R, et al
    Alpha-fetoprotein Decrease from >1000 to <500 ng/ml in Patients with Hepatocellular Carcinoma Leads to Improved Post-Transplant Outcomes.
    Hepatology. 2018 Dec 13. doi: 10.1002/hep.30413.
    PubMed     Abstract available


  91. RAND EB
    Cirrhotic Cardiomyopathy in children with BA: A new objective parameter to predict morbidity and mortality on the waitlist - and beyond!
    Hepatology. 2018 Dec 12. doi: 10.1002/hep.30419.
    PubMed     Abstract available


  92. SIMONETTO DA, Piccolo Serafim L, Gallo de Moraes A, Gajic O, et al
    Management of Sepsis in Patients with Cirrhosis: current evidence and practical approach.
    Hepatology. 2018 Dec 5. doi: 10.1002/hep.30412.
    PubMed     Abstract available


  93. BALE R, Schullian P, Eberle G, Putzer D, et al
    Stereotactic radiofrequency ablation of hepatocellular carcinoma - A histopathological study in explanted livers.
    Hepatology. 2018 Dec 5. doi: 10.1002/hep.30406.
    PubMed     Abstract available


  94. VILAR-GOMEZ E, Vuppalanchi R, Gawrieh S, Ghabril M, et al
    Vitamin E Improves Transplant-free Survival and Hepatic Decompensation among Patients with NASH and Advanced Fibrosis.
    Hepatology. 2018 Dec 1. doi: 10.1002/hep.30368.
    PubMed     Abstract available


    November 2018
  95. MESZAROS M, Ursic-Bedoya J, Faure S, Pageaux GP, et al
    Immunosuppression minimization trials in liver transplantation: can we predict humoral response to asses eligibility?
    Hepatology. 2018 Nov 5. doi: 10.1002/hep.30345.
    PubMed     Abstract available


    October 2018
  96. BAJAJ JS, Moreau R, Kamath PS, Vargas HE, et al
    Acute-on-Chronic Liver Failure: Getting Ready for Prime Time?
    Hepatology. 2018;68:1621-1632.
    PubMed     Abstract available


    September 2018
  97. JUCAUD V, Shaked A, DesMarais M, Sayre P, et al
    Prevalence and impact of de novo DSA during a multicenter immunosuppression withdrawal trial in adult liver transplant recipients.
    Hepatology. 2018 Sep 19. doi: 10.1002/hep.30281.
    PubMed     Abstract available


  98. COSTENTIN CE, Bababekov YJ, Zhu AX, Yeh H, et al
    Is it time to reconsider the Milan Criteria for selecting patients with hepatocellular carcinoma for deceased-donor liver transplantation?
    Hepatology. 2018 Sep 19. doi: 10.1002/hep.30278.
    PubMed     Abstract available


  99. SONG ATW, Abdala E, de Martino RB, Malbouisson LMS, et al
    Liver transplantation for fulminant hepatitis due to yellow fever.
    Hepatology. 2018 Sep 15. doi: 10.1002/hep.30273.
    PubMed     Abstract available


  100. RAEVENS S, Colle I
    Why pulse oximetry is inaccurate in liver cirrhosis - ancient knowledge.
    Hepatology. 2018 Sep 8. doi: 10.1002/hep.30260.
    PubMed     Abstract available


  101. KIM JD, Cho EJ, Ahn C, Park SK, et al
    A Novel Model to Predict 1-Month Risk of Transplant or Death in Hepatitis A-Related Acute Liver Failure.
    Hepatology. 2018 Sep 8. doi: 10.1002/hep.30262.
    PubMed     Abstract available


  102. GE J, Gilroy R, Lai JC
    Receipt of a pediatric liver offer as the first offer reduces waitlist mortality for adult women.
    Hepatology. 2018;68:1101-1110.
    PubMed     Abstract available


    August 2018
  103. ALLEGRETTI AS, Parada XV, Ortiz GA, Long J, et al
    Serum Angiopoietin-2 Predicts Mortality and Kidney Outcomes in Decompensated Cirrhosis.
    Hepatology. 2018 Aug 23. doi: 10.1002/hep.30230.
    PubMed     Abstract available


  104. GORGIS NM, Kennedy C, Lam F, Thompson K, et al
    Clinical Consequences of Cardiomyopathy in Children with Biliary Atresia Requiring Liver Transplantation.
    Hepatology. 2018 Aug 3. doi: 10.1002/hep.30204.
    PubMed     Abstract available


  105. FORDE KA, Fallon MB, Krowka MJ, Sprys M, et al
    Pulse Oximetry is Insensitive for Detection of Hepatopulmonary Syndrome in Patients evaluated for Liver Transplantation.
    Hepatology. 2018 Aug 2. doi: 10.1002/hep.30139.
    PubMed     Abstract available


  106. SQUIRES JE, Rudnick DA, Hardison RM, Horslen S, et al
    Liver Transplant Listing in Pediatric Acute Liver Failure (PALF): Practices and Participant Characteristics.
    Hepatology. 2018 Aug 2. doi: 10.1002/hep.30116.
    PubMed     Abstract available


  107. HUSSAINI T, Krajden M, Mitchell RA, Yoshida EM, et al
    Transplanting Hepatitis C seropositive, nucleic acid test negative donor organs into hepatitis C negative recipients.
    Hepatology. 2018 Aug 2. doi: 10.1002/hep.30121.
    PubMed     Abstract available


    June 2018
  108. MARTINS PN
    Transplantation of Livers from Viremic HCV Positive Donors into HCV Negative Recipients.
    Hepatology. 2018 Jun 11. doi: 10.1002/hep.30106.
    PubMed    


    May 2018
  109. FAN H, Zhu JH
    A novel frailty index improves risk prediction of waitlist mortality over the model for end-stage liver disease score alone.
    Hepatology. 2018;67:2059.
    PubMed    


    April 2018
  110. CULLARO G, Park M, Lai JC
    "Normal" Creatinine Levels Predict Persistent Kidney Injury and Waitlist Mortality in Outpatients with Cirrhosis.
    Hepatology. 2018 Apr 26. doi: 10.1002/hep.30058.
    PubMed     Abstract available


  111. OLORUNTOBA OO, Moylan CA
    "Too Female" for liver transplantation.
    Hepatology. 2018 Apr 20. doi: 10.1002/hep.30053.
    PubMed    


  112. CHOLANKERIL G, Gadiparthi C, Kim D, Ahmed A, et al
    Expanding Donor Pool for Liver Transplantation by Utilizing Hepatitis C Virus-Infected Donors for Uninfected Recipients.
    Hepatology. 2018 Apr 19. doi: 10.1002/hep.30043.
    PubMed    


  113. KWONG AJ, Kim WR, Flemming JA
    De Novo Hepatocellular Carcinoma Among Liver Transplant Registrants in the Direct Acting Antiviral Era.
    Hepatology. 2018 Apr 19. doi: 10.1002/hep.30045.
    PubMed     Abstract available


  114. CHHATWAL J, Bethea ED, Samur S, Chung RT, et al
    Reply to Expanding Donor Pool for Liver Transplantation by Utilizing Hepatitis C Virus-Infected Donors for Uninfected Recipients.
    Hepatology. 2018 Apr 19. doi: 10.1002/hep.30042.
    PubMed    


  115. REAU N, Kwo PY, Rhee S, Brown RS Jr., et al
    Glecaprevir/Pibrentasvir Treatment in Liver or Kidney Transplant Patients With Hepatitis C Virus Infection.
    Hepatology. 2018 Apr 19. doi: 10.1002/hep.30046.
    PubMed     Abstract available


  116. IZZY M, Oh J, Watt KD
    Cirrhotic cardiomyopathy after transplantation: Neither the transient nor innocent bystander.
    Hepatology. 2018 Apr 19. doi: 10.1002/hep.30040.
    PubMed     Abstract available


  117. HOUSSEL-DEBRY P, Coilly A, Fougerou-Leurent C, Jezequel C, et al
    12 weeks of a Ribavirin-free Sofosbuvir and NS5A inhibitor regimen is enough to treat recurrence of hepatitis C after liver transplantation.
    Hepatology. 2018 Apr 10. doi: 10.1002/hep.29918.
    PubMed     Abstract available


  118. MARRERO JA, Kulik LM, Sirlin C, Zhu AX, et al
    Diagnosis, Staging and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases.
    Hepatology. 2018 Apr 6. doi: 10.1002/hep.29913.
    PubMed    


    March 2018
  119. FIRL DJ, Kimura S, McVey J, Hashimoto K, et al
    Reframing the approach to patients with hepatocellular carcinoma: Longitudinal assessment with HALTHCC improves ablate and wait strategy.
    Hepatology. 2018 Mar 31. doi: 10.1002/hep.29907.
    PubMed     Abstract available


  120. YANG MQ, Du Q, Goswami J, Varley PR, et al
    Interferon regulatory factor 1-Rab27a regulated extracellular vesicles promote liver ischemia/reperfusion injury.
    Hepatology. 2018;67:1056-1070.
    PubMed     Abstract available


    February 2018
  121. WU JF, Lee CS, Lin WH, Jeng YM, et al
    Transient elastography is useful in diagnosing biliary atresia and predicting prognosis after hepatoportoenterostomy.
    Hepatology. 2018 Feb 27. doi: 10.1002/hep.29856.
    PubMed     Abstract available


  122. HUANG AC, Mehta N, Dodge JL, Yao FY, et al
    Direct-acting Antivirals Do Not Increase the Risk of Hepatocellular Carcinoma Recurrence after Local-Regional Therapy or Liver Transplant Waitlist Dropout.
    Hepatology. 2018 Feb 24. doi: 10.1002/hep.29855.
    PubMed     Abstract available


  123. ZAMORA-VALDES D, Watt KD, Kellogg TA, Poterucha JJ, et al
    Long-term outcomes of patients undergoing simultaneous Liver Transplantation and Sleeve Gastrectomy.
    Hepatology. 2018 Feb 19. doi: 10.1002/hep.29848.
    PubMed     Abstract available


  124. MAZZAFERRO V, Droz Dit Busset M, Bhoori S
    Alpha-Fetoprotein (AFP) in liver transplantation for HCC: The lower, the better.
    Hepatology. 2018 Feb 9. doi: 10.1002/hep.29835.
    PubMed    


  125. ATKINSON SR, McQuillin A, Morgan MY, Thursz MR, et al
    People who survive an episode of severe alcoholic hepatitis should be advised to maintain total abstinence from alcohol.
    Hepatology. 2018 Feb 2. doi: 10.1002/hep.29825.
    PubMed    


    January 2018
  126. MARTINI S, Caccamo L, Rizzetto M
    Are immunoglobulins against the HBsAg still needed in liver transplantation for hepatitis D?
    Hepatology. 2018 Jan 21. doi: 10.1002/hep.29796.
    PubMed    


  127. KAGEYAMA S, Nakamura K, Fujii T, Ke B, et al
    Recombinant Relaxin Protects Liver Transplants from Ischemia Damage via Hepatocyte Glucocorticoid Receptor: From Bench-to-Bedside.
    Hepatology. 2018 Jan 19. doi: 10.1002/hep.29787.
    PubMed     Abstract available


  128. CHALASANI N, Younossi Z, Lavine JE, Charlton M, et al
    The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases.
    Hepatology. 2018;67:328-357.
    PubMed    


    December 2017
  129. WINTER A, Daures JP, Landais P
    Intention-to-treat survival benefit in liver transplantation: comments on Lai et al.
    Hepatology. 2017 Dec 22. doi: 10.1002/hep.29755.
    PubMed    


  130. CHHATWAL J, Samur S, Bethea ED, Ayer T, et al
    Transplanting HCV-positive livers into HCV-negative patients with preemptive antiviral treatment: A modeling study.
    Hepatology. 2017 Dec 9. doi: 10.1002/hep.29723.
    PubMed     Abstract available


  131. YOUNOSSI ZM, Loomba R, Rinella ME, Bugianesi E, et al
    Current and Future Therapeutic Regimens for Non-alcoholic Fatty Liver Disease (NAFLD) and Non-alcoholic Steatohepatitis (NASH).
    Hepatology. 2017 Dec 9. doi: 10.1002/hep.29724.
    PubMed     Abstract available


  132. KAKABADZE Z, Kakabadze A, Chakhunashvili D, Karalashvili L, et al
    Decellularized human placenta supports hepatic tissue and allows rescue in acute liver failure.
    Hepatology. 2017 Dec 6. doi: 10.1002/hep.29713.
    PubMed     Abstract available


  133. BARI K, Luckett K, Kaiser T, Diwan T, et al
    Hepatitis C Transmission from Seropositive, Non-Viremic Donors to Non-Hepatitis C Liver Transplant Recipients.
    Hepatology. 2017 Dec 2. doi: 10.1002/hep.29704.
    PubMed     Abstract available


    November 2017
  134. JARAMILLO-CALLE DA, Castano Quintero O, Marin JI, Cock-Rada AM, et al
    Is liver transplantation for intractable attacks of porphyria a viable treatment in a developing country?
    Hepatology. 2017 Nov 15. doi: 10.1002/hep.29650.
    PubMed    


    October 2017
  135. YANG JD, Mannalithara A, Piscitello AJ, Kisiel JB, et al
    Impact of Surveillance for Hepatocellular Carcinoma on Survival in Patients with Compensated Cirrhosis.
    Hepatology. 2017 Oct 12. doi: 10.1002/hep.29594.
    PubMed     Abstract available


  136. RAMMOHAN A, Reddy MS, Farouk M, Vargese J, et al
    Pembrolizumab for Metastatic Hepatocellular Carcinoma Following Live Donor Liver Transplantation: The Silver Bullet?
    Hepatology. 2017 Oct 10. doi: 10.1002/hep.29575.
    PubMed     Abstract available


  137. GONZALEZ SA, Trotter JF
    The Rise of the Opioid Epidemic and Hepatitis C Positive Organs: A New Era in Liver Transplantation.
    Hepatology. 2017 Oct 10. doi: 10.1002/hep.29572.
    PubMed     Abstract available


  138. MONTANO-LOZA AJ, Mazurak VC, Ebadi M, Meza-Junco J, et al
    Visceral adiposity increases risk for hepatocellular carcinoma in male patients with cirrhosis and recurrence after liver transplant.
    Hepatology. 2017 Oct 10. doi: 10.1002/hep.29578.
    PubMed     Abstract available


  139. BARBIER L, Ronot M, Aussilhou B, Cauchy F, et al
    Polycystic liver disease: Hepatic venous outflow obstruction lesions of the non-cystic parenchyma have major consequences.
    Hepatology. 2017 Oct 10. doi: 10.1002/hep.29582.
    PubMed     Abstract available


    September 2017
  140. LIU X, Elmofti Y, Kulaga C, Gisi B, et al
    Societal perspectives' analysis for evaluating direct-acting antivirals affordability while awaiting liver transplant.
    Hepatology. 2017 Sep 27. doi: 10.1002/hep.29558.
    PubMed    


  141. MAURO E, Crespo G, Montironi C, Londono MC, et al
    Portal pressure and liver stiffness measurements in the prediction of fibrosis regression after SVR in recurrent hepatitis C.
    Hepatology. 2017 Sep 27. doi: 10.1002/hep.29557.
    PubMed     Abstract available


  142. ONO Y, Perez-Gutierrez A, Nakao T, Dai H, et al
    Graft-infiltrating PD-L1hi cross-dressed dendritic cells regulate anti-donor T cell responses in mouse liver transplant tolerance.
    Hepatology. 2017 Sep 16. doi: 10.1002/hep.29529.
    PubMed     Abstract available


  143. VIONNET J, Pascual M, Testoni B, Combet C, et al
    Late hepatitis B reactivation following DAA-based treatment of recurrent hepatitis C in an anti-HBc-positive liver transplant recipient.
    Hepatology. 2017 Sep 16. doi: 10.1002/hep.29528.
    PubMed    


  144. VANWAGNER LB, Ning H, Whitsett M, Levitsky J, et al
    In Reply To: Xue et al. "Developing a Prediction Model for Cardiovascular Risk after Orthotopic Liver Transplantation".
    Hepatology. 2017 Sep 16. doi: 10.1002/hep.29525.
    PubMed    


  145. XUE FS, Liu YY, Yang GZ
    Developing a Prediction Model for Cardiovascular Risk after Orthotopic Liver Transplantation.
    Hepatology. 2017 Sep 16. doi: 10.1002/hep.29527.
    PubMed    


  146. MARSHALL K, Jin J, Atkinson C, Alawieh A, et al
    Natural IgM initiates an inflammatory response important for both hepatic ischemia reperfusion injury and regeneration.
    Hepatology. 2017 Sep 7. doi: 10.1002/hep.29512.
    PubMed     Abstract available


    August 2017
  147. KULIK L, Heimbach JK, Zaiem F, Almasri J, et al
    Therapies for Patients with Hepatocellular Carcinoma Awaiting for Liver Transplantation: a Systematic Review and Meta-analysis.
    Hepatology. 2017 Aug 31. doi: 10.1002/hep.29485.
    PubMed     Abstract available


  148. PARIKH ND, Marrero WJ, Wang J, Steuer J, et al
    Projected increase in obesity and non-alcoholic steatohepatitis-related liver transplantation waitlist additions in the United States.
    Hepatology. 2017 Aug 17. doi: 10.1002/hep.29473.
    PubMed     Abstract available


  149. DE HAAS RJ, Lim C, Bhangui P, Salloum C, et al
    Curative Salvage Liver Transplantation in Cirrhotic patients with Hepatocellular Carcinoma: An intention-to-treat analysis.
    Hepatology. 2017 Aug 14. doi: 10.1002/hep.29468.
    PubMed     Abstract available


  150. LAI JC, Covinsky KE, Dodge JL, Boscardin WJ, et al
    Development of a novel frailty index to predict mortality in patients with end-stage liver disease.
    Hepatology. 2017;66:564-574.
    PubMed     Abstract available


  151. AZOULAY D, Lahat E, Salloum C, Compagnon P, et al
    Heterotopic liver retransplantation for impossible former graft explantation.
    Hepatology. 2017;66:655-657.
    PubMed    


    July 2017
  152. GU J, Jeong S, Xia Q
    Intrahepatic cholangiocarcinoma arising from HBV Infection may be a highly selected population for liver transplantation.
    Hepatology. 2017 Jul 31. doi: 10.1002/hep.29413.
    PubMed    


  153. LUCEY MR
    Redefining successful treatment of severe alcoholic hepatitis.
    Hepatology. 2017 Jul 24. doi: 10.1002/hep.29398.
    PubMed    


  154. VANWAGNER LB, Ning H, Whitsett M, Levitsky J, et al
    A Point-based Prediction Model for Cardiovascular Risk in Orthotopic Liver Transplantation: The CAR-OLT Score.
    Hepatology. 2017 Jul 13. doi: 10.1002/hep.29329.
    PubMed     Abstract available


  155. CARDOSO FS, Pereira R, Alexandrino G, Bagulho L, et al
    Futility of care in patients with acute-on-chronic liver failure.
    Hepatology. 2017;66:292-294.
    PubMed    


    June 2017
  156. LAI Q, Vitale A, Iesari S, Finkenstedt A, et al
    Intention-to-treat survival benefit of liver transplantation in patients with hepatocellular cancer.
    Hepatology. 2017 Jun 27. doi: 10.1002/hep.29342.
    PubMed     Abstract available


  157. KWONG AJ, Goel A, Mannalithara A, Kim WR, et al
    Improved Post-Transplant Mortality After Share 35 for Liver Transplantation.
    Hepatology. 2017 Jun 6. doi: 10.1002/hep.29301.
    PubMed     Abstract available


    May 2017
  158. GANE E
    Is HBIG still needed after liver transplantation for CHB?
    Hepatology. 2017 May 26. doi: 10.1002/hep.29292.
    PubMed    


  159. HAYASHI PH, Rockey D, Fontana RJ, Tillmann HL, et al
    Death and Liver Transplantation within Two Years of Onset of Drug-Induced Liver Injury.
    Hepatology. 2017 May 23. doi: 10.1002/hep.29283.
    PubMed     Abstract available


  160. SAMOYLOVA ML, Nigrini MJ, Dodge JL, Roberts JP, et al
    Biases in the reporting of hcc tumor sizes on the liver transplant waiting list.
    Hepatology. 2017 May 18. doi: 10.1002/hep.29269.
    PubMed     Abstract available


  161. SAXENA V, Khungar V, Verna EC, Levitsky J, et al
    Safety and Efficacy of Current DAA Regimens in Kidney and Liver Transplant Recipients with Hepatitis C: Results from the HCV-TARGET Study.
    Hepatology. 2017 May 15. doi: 10.1002/hep.29258.
    PubMed     Abstract available


    April 2017
  162. DENEAU MR, El-Matary W, Valentino PL, Abdou R, et al
    The natural history of primary sclerosing cholangitis in 781 children: A multicenter, international collaboration.
    Hepatology. 2017 Apr 8. doi: 10.1002/hep.29204.
    PubMed     Abstract available


    March 2017
  163. FUNG J, Wong T, Chok K, Chan A, et al
    Long Term Outcomes of Entecavir Monotherapy for Chronic Hepatitis B after Liver Transplantation: Results up to 8 years.
    Hepatology. 2017 Mar 31. doi: 10.1002/hep.29191.
    PubMed     Abstract available


  164. AHMED A, Gonzalez SA, Cholankeril G, Perumpail RB, et al
    Treatment of Patients Waitlisted for Liver Transplant with an All-Oral DAAs is a Cost-Effective Treatment Strategy in the United States.
    Hepatology. 2017 Mar 3. doi: 10.1002/hep.29137.
    PubMed     Abstract available


  165. ALONSO EM, Horslen SP, Behrens EM, Doo E, et al
    Pediatric acute liver failure of undetermined cause: A research workshop.
    Hepatology. 2017;65:1026-1037.
    PubMed     Abstract available


    February 2017
  166. CADIER B, Bulsei J, Nahon P, Seror O, et al
    Early detection and curative treatment of hepatocellular carcinoma: A cost-effectiveness analysis in France and in the United States.
    Hepatology. 2017 Feb 8. doi: 10.1002/hep.28961.
    PubMed     Abstract available


  167. LEE MW, Raman SS, Asvadi NH, Siripongsakun S, et al
    Radiofrequency Ablation of Hepatocellular Carcinoma as Bridge Therapy to Liver Transplantation: A Ten Year Intention-to-treat Analysis.
    Hepatology. 2017 Feb 7. doi: 10.1002/hep.29098.
    PubMed     Abstract available


    January 2017
  168. BOYD A, Miailhes P, Lacombe K, Zoulim F, et al
    Potential effect of lamivudine-induced S-gene mutations on liver-related pathogenesis in hepatitis D virus infection.
    Hepatology. 2017 Jan 19. doi: 10.1002/hep.29062.
    PubMed    


  169. VERNA EC
    The Dynamic Landscape of Liver Transplant in the Era of Effective HCV Therapy.
    Hepatology. 2017 Jan 17. doi: 10.1002/hep.29054.
    PubMed    


  170. SHAKED A, Chang BL, Barnes MR, Sayre P, et al
    An ectopically expressed serum miRNA signature is prognostic, diagnostic, and biologically related to liver allograft rejection.
    Hepatology. 2017;65:269-280.
    PubMed     Abstract available


  171. TROTTER JF
    An ectopically expressed serum miRNA signature is prognostic, diagnostic, and biologically related to liver allograft rejection.
    Hepatology. 2017;65:15-17.
    PubMed    


    December 2016
  172. CILLO U, Vitale A, Polacco M, Fasolo E, et al
    Liver transplantation for hepatocellular carcinoma through the lens of transplant benefit.
    Hepatology. 2016 Dec 23. doi: 10.1002/hep.28998.
    PubMed    


  173. SAVALE L, Sattler C, Coilly A, Conti F, et al
    Long-term outcome in liver transplantation candidates with portopulmonary hypertension.
    Hepatology. 2016 Dec 20. doi: 10.1002/hep.28990.
    PubMed     Abstract available


  174. GUPTA R, Gupta J
    Strategies to improve survival of patients with intrahepatic cholangiocarcinoma undergoing liver transplantation.
    Hepatology. 2016 Dec 20. doi: 10.1002/hep.28994.
    PubMed    


  175. SAPISOCHIN G, Bruix J
    In response to: Strategies to improve survival of patients with intrahepatic cholangiocarcinoma undergoing liver transplantation.
    Hepatology. 2016 Dec 20. doi: 10.1002/hep.28993.
    PubMed    


  176. MARTINI S, Salizzoni M, David E, Tandoi F, et al
    Favorable short-term outcome of HCV-positive liver graft with bridging fibrosis: A plea for very early viral eradication.
    Hepatology. 2016 Dec 16. doi: 10.1002/hep.28978.
    PubMed     Abstract available


    November 2016
  177. DE VRIES EM, de Krijger M, Farkkila M, Arola J, et al
    Validation of the Prognostic Value of Histologic Scoring Systems in Primary Sclerosing Cholangitis; An International Cohort Study.
    Hepatology. 2016 Nov 23. doi: 10.1002/hep.28963.
    PubMed     Abstract available


  178. CHHATWAL J, Samur S, Kues B, Ayer T, et al
    Optimal Timing of Hepatitis C Treatment for Patients on the Liver Transplant Waiting List.
    Hepatology. 2016 Nov 5. doi: 10.1002/hep.28926.
    PubMed     Abstract available


  179. FLEMMING JA, Kim WR, Brosgart CL, Terrault NA, et al
    Reduction in liver transplant wait-listing in the era of direct-acting antiviral therapy.
    Hepatology. 2016 Nov 5. doi: 10.1002/hep.28923.
    PubMed     Abstract available


    October 2016
  180. KALAFATELI M, Wickham F, Burniston M, Cholongitas E, et al
    Development and validation of a mathematical equation to estimate glomerular filtration rate in cirrhosis: The rfh cirrhosis Gfr.
    Hepatology. 2016 Oct 25. doi: 10.1002/hep.28891.
    PubMed     Abstract available


  181. EMOND JC, Griesemer AD
    Tolerance in clinical liver transplantation: The long road ahead.
    Hepatology. 2016 Oct 7. doi: 10.1002/hep.28862.
    PubMed    


    September 2016
  182. MULLIGAN DC
    The ongoing quest to find the appropriate patients to transplant with hepatocellular carcinoma: Milan to san Francisco to Toronto and beyond.
    Hepatology. 2016 Sep 19. doi: 10.1002/hep.28841.
    PubMed    


    August 2016
  183. TAWAR RG, Heydmann L, Bach C, Schuttrumpf J, et al
    Broad neutralization of hepatitis C virus resistant variants by Civacir(R) hepatitis C immune globulin.
    Hepatology. 2016 Aug 17. doi: 10.1002/hep.28767.
    PubMed     Abstract available


    July 2016
  184. LANGBERG KM, Taddei TH
    Balancing quality with quantity: The role of palliative care in managing decompensated cirrhosis.
    Hepatology. 2016 Jul 7. doi: 10.1002/hep.28717.
    PubMed    


    March 2016
  185. FRIEDRICH K, Smit M, Brune M, Giese T, et al
    CD14 is associated with biliary stricture formation.
    Hepatology. 2016 Mar 11. doi: 10.1002/hep.28543.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Transplantation is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: